Kangmei Pharmaceutical received the Notice of Investigation from China Securities Regulatory Commission, which pointed out: As your company is suspected of violating laws and regulations in information disclosure, according to the relevant provisions of the Securities Law of People's Republic of China (PRC), I will decide to initiate an investigation on your company, so please cooperate.
For Kangmei Pharmaceutical, the fourth quarter of 20 18 was the darkest quarter since the listing of the company 17, and the tragic degree far exceeded the financial crisis in 2008 and the stock market adjustment in 20 15.
In the secondary market, Kangmei Pharmaceutical fell all the way after the opening of18/kloc-0+06, and then stopped at 10: 40. In the last few minutes before closing, the stock rose and finally closed down 5.97%. In the following three trading days, Kangmei Pharmaceutical continued to be banned by big orders without any resistance.